These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 26627608)

  • 1. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
    Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
    Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
    Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
    Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
    Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
    Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 6. Asia-Pacific Colorectal Screening Score Combined With Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.
    Xu J; Rong L; Gu F; You P; Ding H; Zhai H; Wang B; Li Y; Ma X; Yin F; Yang L; He Y; Sheng J; Jin P
    Clin Gastroenterol Hepatol; 2023 Jun; 21(6):1627-1636.e4. PubMed ID: 36113828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool.
    Corte C; Zhang L; Chen J; Westbury S; Shaw J; Yeoh KG; Leong R
    J Gastroenterol Hepatol; 2016 Feb; 31(2):370-5. PubMed ID: 26485170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
    Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
    Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test.
    He XX; Yuan SY; Li WB; Yang H; Ji W; Wang ZQ; Hao JY; Chen C; Chen WQ; Gao YX; Li LB; Cheng KL; Qian JM; Wang L; Li JN
    BMC Gastroenterol; 2019 Dec; 19(1):226. PubMed ID: 31881948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
    Tao S; Hoffmeister M; Brenner H
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):478-85. PubMed ID: 24022090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.
    Kim DH; Cha JM; Shin HP; Joo KR; Lee JI; Park DI
    J Clin Gastroenterol; 2015 Jan; 49(1):41-9. PubMed ID: 24583751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-adapted Variation in Screening Interval of Fecal Immunochemical Test May Improve its Participation and Colonoscopy Acceptance.
    Kwak MS; Cha JM; Yoon JY; Jeon JW; Shin HP; Joo KR; Lee JI
    J Clin Gastroenterol; 2017 Oct; 51(9):825-830. PubMed ID: 27824639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Asia-Pacific Colorectal Screening score in stratifying the risk of advanced colorectal neoplasia: A meta-analysis and systematic review.
    Luu MN; Trinh NA; Tran TLT; Dang TP; Hiyama T; Quach DT
    J Gastroenterol Hepatol; 2024 Jun; 39(6):1000-1007. PubMed ID: 38425009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of clinical risk stratification and fecal immunochemical test is useful for identifying persons with high priority of early colonoscopy.
    Jung YS; Park CH; Kim NH; Park JH; Park DI; Sohn CI
    Dig Liver Dis; 2018 Mar; 50(3):254-259. PubMed ID: 29198569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of advanced colorectal neoplasia for colorectal cancer screening.
    Wong MC; Lam TY; Tsoi KK; Chan VC; Hirai HW; Ching JY; Sung JJ
    Am J Prev Med; 2014 May; 46(5):433-9. PubMed ID: 24745632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualized colorectal cancer screening based on the clinical risk factors: beyond family history of colorectal cancer.
    Park CH; Kim NH; Park JH; Park DI; Sohn CI; Jung YS
    Gastrointest Endosc; 2018 Jul; 88(1):128-135. PubMed ID: 29510145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Concentrations of Hemoglobin Determined by Fecal Immunochemical Tests and Long-term Development of Advanced Colorectal Neoplasia.
    Grobbee EJ; Schreuders EH; Hansen BE; Bruno MJ; Lansdorp-Vogelaar I; Spaander MCW; Kuipers EJ
    Gastroenterology; 2017 Nov; 153(5):1251-1259.e2. PubMed ID: 28760383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
    Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
    BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary application of the Asia-Pacific colorectal screening score combined with the quantitative fecal occult blood in colorectal neoplasia screening].
    Kang Q; Li N; Wang RF; Yang L; Jin P; Sheng JQ
    Zhonghua Yi Xue Za Zhi; 2021 Dec; 101(46):3825-3828. PubMed ID: 34895425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.